AbbVie vs AstraZeneca

ABBV · AZN

In fiscal year 2025 AbbVie reported $61.2B in revenue against AstraZeneca's $58.7B, 1.04× as much.

AbbVie vs AstraZeneca
MeasureABBVAZNGap
Revenue$61.2B$58.7B×1.04
Cost of revenue$18.2B$10.6B×1.71
Operating income$15.1B$13.7B×1.10
Net income$4.2B$10.2B×2.42
EPS (diluted)2.366.54×2.77
Total assets$134B$114B×1.17
Total liabilities$137B$65.4B×2.10
Shareholders' equity−$3.3B$48.7B—
Cash$5.2B$5.7B×1.09
Long-term debt$64.5B$24.7B×2.61
Net margin6.9%17.4%×2.52
Operating margin24.6%23.4%×1.05
Operating cash flow$19.0B$14.6B×1.31
Capital expenditure$1.2B$2.8B×2.31
Free cash flow$17.8B$11.8B×1.51
R&D expense$9.1B$14.2B×1.56
Dividends paid$11.7B$5.0B×2.35
Income tax expense$2.4B$2.2B×1.09
Share buybacks$980M$521M×1.88

The larger of the two figures is in bold. Larger is not automatically better: on debt, cost and tax a bigger number is simply a bigger number. This site reports the figures and leaves the judgement to you.

Revenue, year by year

AbbVie · 2016–2025

$25.6B2016$28.2B2017$32.8B2018$33.3B2019$45.8B2020$56.2B2021$58.1B2022$54.3B2023$56.3B2024$61.2B2025

AstraZeneca · 2015–2025

$24.7B2015$23.0B2016$22.5B2017$22.1B2018$24.4B2019$26.6B2020$37.4B2021$44.4B2022$45.8B2023$54.1B2024$58.7B2025

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=AbbVie vs AstraZeneca |url=https://companiesranked.com/en/compare/abbvie-vs-astrazeneca |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). AbbVie vs AstraZeneca. CompaniesRanked. https://companiesranked.com/en/compare/abbvie-vs-astrazeneca

BibTeX

@misc{companiesranked-en-compare-abbvie-vs-astrazeneca-2026,
  author       = {{CompaniesRanked}},
  title        = {{AbbVie vs AstraZeneca}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/compare/abbvie-vs-astrazeneca}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← AbbVie · AstraZeneca →